Memphasys

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Memphasys is a listed Australian company (ASX: MEM, formerly Mediland Pharm) that was initially focussed on proprietary electrophoresis and polymer membrane technology.

Memphasys has subsequently focussed its business development in the artificial reproduction and fertility market.

Contact Details

34-36 Richmond Road , Homebush West SYDNEY NSW 2140
02 8415 7300
www.memphasys.com

Lists and Charts

Share price

Memphasys
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Company Share Transactions

25/09/20
$312.50k Other
Memphasys
27/08/20
$104.17k Other
Memphasys
Total value as at the date of the transaction
Powered by Morningstar ®

      Company Activity

      		 NEW ROLE: David Ali, Acting CEO, Executive Director 01 Aug 2024
      		NEW ROLE: David Ali, Acting CEO, Executive Director 01 Aug 2024
      		NEW ROLE: Jessie Tao, Chief Financial Officer 24 Nov 2020
      		NEW ROLE: Tracey L Cray, Non-Executive Director 03 Nov 2020
      		NEW ROLE: Jhon Shen, Executive Director 03 Nov 2020
      		NEW ROLE: Yeshween Mudaliar, Managing Director 03 Nov 2020
      		NEW ROLE: Xiaolei Cui, Non-Executive Director 03 Nov 2020
      		NEW ROLE: Indira Naidu, Company Secretary 03 Nov 2020
      Peter French
      		NEW ROLE: Peter French, Non-Executive Chair 03 Nov 2020

    Related Information

    Access to our data for Memphasys is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    Memphasys is included in 1 list - Public Companies - non WA.

    For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

    Subscribe today

    X